Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$TWST Q3 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.56 down -264.71% YoY • Reported revenue of $118.38M up 23.24% YoY • Twist Bioscience expects full fiscal year 2026 revenue in the range of $456 million to $457 million and fourth quarter revenue of approximately $123 million to $124 million with adjusted EBITDA breakeven.

Price since post

Full Details

Advertisement|Remove ads.